Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xingbo Xu

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Cell Metabolism|August 14, 2024
Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASHLiang Tao, Xinquan Yang, Chaodong Ge, et al.
Molecular Therapy. Oncology|July 29, 2024
High CIB1 expression in colorectal cancer liver metastases correlates with worse survival and the replacement histopathological growth patternShuang Fan, Johannes Robert Fleischer, Lolita Dokshokova, et al.
JCI Insight|August 22, 2022
Axon guidance receptor ROBO3 modulates subtype identity and prognosis via AXL-associated inflammatory network in pancreatic cancerNiklas Krebs, Lukas Klein, Florian Wegwitz, et al.
The EMBO Journal|November 22, 2021
Postnatal expression of the lysine methyltransferase SETD1B is essential for learning and the regulation of neuron-enriched genesAlexandra Michurina, M Sadman Sakib, Cemil Kerimoglu, et al.
Molecular Cancer|January 23, 2023
Molecular differences of angiogenic versus vessel co-opting colorectal cancer liver metastases at single-cell resolutionJohannes Robert Fleischer, Alexandra Maria Schmitt, Gwendolyn Haas, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Cell Metabolism|August 14, 2024
Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASHLiang Tao, Xinquan Yang, Chaodong Ge, et al.
Molecular Therapy. Oncology|July 29, 2024
High CIB1 expression in colorectal cancer liver metastases correlates with worse survival and the replacement histopathological growth patternShuang Fan, Johannes Robert Fleischer, Lolita Dokshokova, et al.
JCI Insight|August 22, 2022
Axon guidance receptor ROBO3 modulates subtype identity and prognosis via AXL-associated inflammatory network in pancreatic cancerNiklas Krebs, Lukas Klein, Florian Wegwitz, et al.
The EMBO Journal|November 22, 2021
Postnatal expression of the lysine methyltransferase SETD1B is essential for learning and the regulation of neuron-enriched genesAlexandra Michurina, M Sadman Sakib, Cemil Kerimoglu, et al.
Molecular Cancer|January 23, 2023
Molecular differences of angiogenic versus vessel co-opting colorectal cancer liver metastases at single-cell resolutionJohannes Robert Fleischer, Alexandra Maria Schmitt, Gwendolyn Haas, et al.
Pageof 5